Tocilizumab for relapsing and remitting giant cell arteritis: a case series of 16 subjects and implications for clinical practice

HIGHLIGHTS

• who: Pratyasha Saha from the assessing hub is St George`s University Hospitals NHS Foundation Trust Hospital, serving a population of , million in have published the paper: Tocilizumab for relapsing and remitting giant cell arteritis: a case series of 16 subjects and implications for clinical practice, in the Journal: (JOURNAL) of 10,/01/2021
• what: The authors show that steroid dosing and duration can be reduced with tocilizumab, and that all subjects received full funding for treatment.

SUMMARY

For GCA is 70 years of age, and it is seven times more . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.